Turning 40 is not a diagnosis, and fatigue, weight gain, lower libido, or slower recovery are not proof of “low testosterone.

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Olumiant (baricitinib), a once-daily pill, for the treatment of pediatric patients 12 years ...

Biotech competition with China has become a bigger focus in Washington, but it was notably absent from the White House’s ...

Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin efsitora ...

A recent study finds nearly 17% of children using GLP-1 drugs developed nutritional deficiencies within a year, raising ...

For some people, losing weight is frustratingly difficult. They may have tried changing their meals, walking more often, joining a gym, or following ...

Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues RE Sep. 18 US FDA approves Lilly's breast cancer drug combo RE Sep. 18 Eli Lilly and Company Receives Fda Approval for ...

Spread the love“`html Imagine you’re scrolling through your social media feed. An influencer you trust raves about a new, all ...

Kailera Therapeutics initiated with a Hold rating due to efficacy data released and long timelines for key catalysts. Click for key KLRA catalysts and risks.

Patients with advanced pancreatic cancer—a disease that typically kills within a year—lived nearly twice as long when a ...

Discover weight loss apps for tracking workouts and nutrition, with features that can help with meal planning, food logging, ...